News - FDA Approves Abilify (Aripiprazole) for Treatment of Acute Bipolar Mania, Including Manic and Mixed Episodes

	Unregistered User Click here if this is not your Personal Edition
		Contact Us \| Free E-Mail Updates \| Journals \| Register a colleague

Psychiatry Other

EXPLORE :

Most Read News

All News

All Webcasts / CME

All Cases

Congress Resource Centre

All Medical Resources

My Personal Edition

Warning | Privacy

Recent news - Psychiatry Other

	Study Examines Course and Treatment of Unexplained Chest Pain - (DGNews)
	Hypertension May Predict Dementia in Older Adults With Certain Cognitive Deficits - (DGNews)
	Latrepirdine May Have Beneficial Effects in Patients With Huntington's Disease - (DGNews)
	Physical Activity Associated With Healthier Aging, Mentally and Physically - (DGNews)
	Monitoring of High-Risk Medications Unchanged Despite FDA Warnings - (DGNews)

News archive

Recent webcasts/CME - Psychiatry Other

Differentiating Bipolar Disorder From Major Depressive Disorder: A Case-Based Approach to Improving Diagnosis and Treatment in Primary Care
25-Year-Old Man With Depression
31-Year-Old Woman With Depression and Emotional Lability (Or, All That Goes Up and Down Is Not Bipolar)

Applying Evidence to Practice in Major Depressive Disorder: An Interactive Panel Discussion

Pediatric Psychiatry: Clinical Pearls for the Primary Care Clinician

Webcasts/CME archive

Recent cases - Psychiatry Other

	A Migraine Variant With Abdominal Colic And Alice In Wonderland Syndrome: A Case Report And Review
	Self-Inflicted Penetrating Eye Injuries Using A Razor Blade: Case Report
	Munchausen Syndrome In The Emergency Department Mostly Difficult, Sometimes Easy To Diagnose: A Case Report And Review Of The Literature
	11p Microdeletion Including WT1 but not PAX6, Presenting with Cataract, Mental Retardation, Genital Abnormalities and Seizures: Case Report
	Comorbidity of Asperger's Syndrome and Bipolar Disorder

Cases archive

my personal edition > psychiatry other > news

E-Mail this DGNews to a colleague

DGNews

FDA Approves Abilify (Aripiprazole) for Treatment of Acute Bipolar Mania, Including Manic and Mixed Episodes

NEW YORK, NY -- October 4, 2004 -- The FDA has approved Abilify® (aripiprazole), for the treatment of acute bipolar mania, including manic and mixed episodes in patients with bipolar disorder.

More than 2 million Americans suffer from bipolar I disorder, a condition that causes extreme mood changes alternating between episodes of mania (highs), when the person's mood is elated and judgment impaired, and depression (lows), when the person may feel hopeless and believe they cannot be helped.

For bipolar I disorder, medicine plays a key role in helping manage symptoms. However, taking medicine as prescribed can be difficult. Because patients vary in their response to medication, it is important to have several treatment options available to help healthcare providers find an optimal treatment plan for each patient.

SOURCE: Bristol-Myers Squibb

E-Mail this DGNews to a colleague To print, use this version